These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17688492)

  • 21. Efficient estimation of the distribution of quality-adjusted survival time.
    Zhao H; Tsiatis AA
    Biometrics; 1999 Dec; 55(4):1101-7. PubMed ID: 11315054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life predictors in breast cancer women.
    Rabin EG; Heldt E; Hirakata VN; Fleck MP
    Eur J Oncol Nurs; 2008 Feb; 12(1):53-7. PubMed ID: 17884731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC; Wang W; Hartzema AG; Wagner S
    Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to quality indicators and survival in patients with breast cancer.
    Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
    Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic studies in cancer of the breast: optimal use of current statistical tools].
    Bonichon F
    Bull Cancer; 1996 Dec; 83(12):1046-52. PubMed ID: 9116374
    [No Abstract]   [Full Text] [Related]  

  • 26. Efron-type measures of prediction error for survival analysis.
    Gerds TA; Schumacher M
    Biometrics; 2007 Dec; 63(4):1283-7. PubMed ID: 17651459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced smoothing for rank regression with censored survival times.
    Brown BM; Wang YG
    Stat Med; 2007 Feb; 26(4):828-36. PubMed ID: 16646005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A more flexible regression-to-the-mean model with possible stratification.
    Chen S; Cox C; Cui L
    Biometrics; 1998 Sep; 54(3):939-47. PubMed ID: 9750243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing equality of survival functions of quality-adjusted lifetime.
    Zhao H; Tsiatis AA
    Biometrics; 2001 Sep; 57(3):861-7. PubMed ID: 11550938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C; Suh J; Stea B; Nabid A; Hackman J
    Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying influential families using regression diagnostics for generalized estimating equations.
    Ziegler A; Blettner M; Kastner C; Chang-Claude J
    Genet Epidemiol; 1998; 15(4):341-53. PubMed ID: 9671985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths.
    Kurland BF; Heagerty PJ
    Biostatistics; 2005 Apr; 6(2):241-58. PubMed ID: 15772103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of ordinal repeated measures data using generalized estimating equation].
    Liu X; Zhang JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):798-800. PubMed ID: 17037756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistics in review. Part 2: generalised linear models, time-to-event and time-series analysis, evidence synthesis and clinical trials.
    Moran JL; Solomon PJ
    Crit Care Resusc; 2007 Jun; 9(2):187-97. PubMed ID: 17536991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of two bias-corrected covariance estimators for generalized estimating equations.
    Lu B; Preisser JS; Qaqish BF; Suchindran C; Bangdiwala SI; Wolfson M
    Biometrics; 2007 Sep; 63(3):935-41. PubMed ID: 17825023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.
    Kafadar K; Prorok PC
    Stat Med; 2009 Jul; 28(16):2116-46. PubMed ID: 19424959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials: odds ratios and multiple regression models--why and how to assess them.
    Sobh M; Cleophas TJ; Hadj-Chaib A; Zwinderman AH
    Am J Ther; 2008; 15(1):44-52. PubMed ID: 18223353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimates of clinically useful measures in competing risks survival analysis.
    Ambrogi F; Biganzoli E; Boracchi P
    Stat Med; 2008 Dec; 27(30):6407-25. PubMed ID: 18937229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research.
    Johnston KM; Gustafson P; Levy AR; Grootendorst P
    Stat Med; 2008 Apr; 27(9):1539-56. PubMed ID: 17847052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified pseudolikelihood approach for analysis of longitudinal data.
    Wang YG; Zhao Y
    Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.